Team uses AlphaFold AI to redesign gene-editing proteins to make them safer
Scored daily by a customisable AI persona to surface the most relevant engineering leadership news.
AlphaFold redesigning gene-editing proteins is cutting-edge AI application in biotech with high technical depth and novelty.
Researchers used AlphaFold to redesign Cas9 proteins, targeting regions responsible for off-target DNA edits. By building a library of off-target sites and applying AI-driven protein structure analysis, they identified and modified key Cas9 domains to reduce unintended edits. The approach aims to improve the safety of gene-editing therapies by lowering error rates in large-scale cell editing.
John Timmer — John is Ars Technica's science editor. He has a Bachelor of Arts in Biochemistry from Columbia University, and a Ph.D. in Molecular and Cell Biology from the University of California, Berkeley. John has done over a decade's worth of research in...